Join
Live feed
·
INSIDERFilingvia Quantisnow
Eyegate Pharmaceuticals, Inc. logo

SEC Form 4: Sarah Romano disposed of $8,128 worth of Common Stock (1,282 units at $6.34), decreasing ownership by 5% to 24,331 units

ByQuantisnow·Wall Street's wire, on your screen.
EYEG· Eyegate Pharmaceuticals, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EYEG (Eyegate Pharmaceuticals, Inc.) and more on Quantisnow.